Thor Medical ASA (OSL:TRMED)
kr 1.018 0.014 (1.39%) Market Cap: 239.09 Mil Enterprise Value: 210.39 Mil PE Ratio: 0 PB Ratio: 0.93 GF Score: 39/100

Q2 2021 Nordic Nanovector ASA Earnings Call Transcript

Aug 27, 2021 / 06:30AM GMT
Release Date Price: kr21.54 (+11.67%)
Malene Brondberg
Nordic Nanovector ASA - CFO & Interim CEO

Good morning, everyone, and welcome to the Nordic Nanovector Q2 and First Half 2021 Call. I'm Malene Brondberg, Interim CEO and CFO. And with me today, I have our Chief Operating Officer, Marco Renoldi.

Today's earnings release report and the slides for this call are available on our website at nordicnanovector.com. Please note this call is being webcasted live, and a recording will be made available on the Nordic Nanovector website. Questions for the Q&A session can be submitted as usually throughout the presentation through the webcast platform, and we will attempt, of course, to answer as many as those (inaudible).

Please turn to the next slide. As always, we need to go through this slide. We need to advise you that this conference call would contain forward-looking statements, and such forward-looking statements are subject to risks and the uncertainty that could cause actual results to differ materially from expectations, and more information can be found on this slide.

Please turn to the next slide.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot